In a closely watched review, an FDA panel voted 13 to 10 to recommend authorization of Merck's COVID-19 pill, though with many caveats.
Merck's COVID-19 pill narrowly wins FDA panel's support
miscellaneousmiscellaneous / miscellaneous 4 years ago 203 Views comments
Comments